Background: Restless legs syndrome is a common yet frequently undiagnosed sensorimotor
disorder. In 1995, the International Restless Legs Syndrome Study Group developed …

A systematic literature review and meta-analyses (where appropriate) were performed to
update the previous AASM practice parameters on the treatments, both dopaminergic and …

Restless legs syndrome (RLS) is a somatosensory network disorder that is clinically
diagnosed according to four main criteria: an urge to move the legs, usually associated with …

The restless legs syndrome is a common disorder that encompasses an idiopathic form of
genetic or unknown origin and symptomatic forms associated with many causes …

Only in the last three decades, the restless legs syndrome (RLS) has been examined in
randomized controlled trials. The Movement Disorder Society (MDS) commissioned a task …

Background and Objectives: Restless legs syndrome (RLS) is a common, underdiagnosed
neurological movement disorder of undetermined etiology. The primary treatments for …

OBJECTIVES: Augmentation of symptom severity is the main complication of dopaminergic
treatment of restless legs syndrome (RLS). The current article reports on the considerations …

BACKGROUND: Restless legs syndrome (RLS) is a chronic persisting disease, which is
managed with palliative medications that are likely to be required for a patient's lifetime. It is …

Dopamine agonists for the treatment of restless legs syndrome - Scholz, H - 2011 | Cochrane
Library Skip to Content Cookies Our site uses cookies to improve your experience. You can …

Results 235 participants were included in this report (intention-to-treat cohort), of which 127
completed the 12-month follow-up (per-protocol cohort). Mean age was 52 years, 55% had …